Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.

Source:http://linkedlifedata.com/resource/pubmed/id/12162821

Hum. Gene Ther. 2002 Jul 20 13 11 1391-412

Download in:

View as

Triples

General Info

PMID
12162821